Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
YAO, JAMES C
One or more keywords matched the following items that are connected to YAO, JAMES C
Item TypeName
Academic Article Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Academic Article Molecular targeted therapy for neuroendocrine tumors.
Academic Article mTOR inhibition, a potential novel approach for bronchial carcinoids.
Academic Article The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Academic Article Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma.
Academic Article Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.
Academic Article Neuroendocrine tumors: novel approaches in the age of targeted therapy.
Academic Article New strategies for advanced neuroendocrine tumors in the era of targeted therapy.
Academic Article PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.
Academic Article Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience.
Academic Article Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.
Academic Article Perspectives in the development of novel treatment approaches.
Academic Article Everolimus for advanced pancreatic neuroendocrine tumors.
Academic Article Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors.
Academic Article Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Na?ve Advanced Pancreatic Neuroendocrine Tumors.
Concept TOR Serine-Threonine Kinases
Search Criteria
  • TOR Serine Threonine Kinases